Peter A. Bartenstein
Munich, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 479 publications
Longitudinal comparison of adaptive neuroplasticity in two rat models of unilateral vestibulopathy by dual-tracer [18F]FDG and [18F]UCB-H PET.
Journal: NeuroImage
Published: September 12, 2025
Feasibility of different meningioma delineation approaches on [18F]SiTATE PET/CT imaging.
Journal: Discover oncology
Published: April 27, 2025
TGF-β1-based restoration of sodium iodide symporter expression in radioiodine-refractory differentiated thyroid cancer via engineered MSCs.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: January 21, 2025
Myeloid cell-specific loss of NPC1 in mice recapitulates microgliosis and neurodegeneration in patients with Niemann-Pick type C disease.
Journal: Science translational medicine
Published: December 04, 2024
Peptide Receptor Radionuclide Therapy Using 90Y- and 177Lu-DOTATATE Modulating Atherosclerotic Plaque Inflammation: Longitudinal Monitoring by 68Ga-DOTATATE Positron Emissions Tomography/Computer Tomography.
Journal: Diagnostics (Basel, Switzerland)
Published: October 14, 2024
Lenticulostriatal Ischemia Shows Relevant SSTR Expression on PET/CT Imaging Using the Novel SSTR-Targeting Peptide 18 F-SiTATE.
Journal: Clinical nuclear medicine
Published: October 02, 2024
Author Correction: Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE.
Journal: Nature neuroscience
Published: August 14, 2024
Partial volume effect correction impairs the diagnostic utility of [18F]-THK-5351 PET in nonfluent-agrammatic variant primary progressive aphasia.
Journal: NeuroImage. Clinical
Published: August 12, 2024
Upregulation of SSTR2 Expression and Radioligand Binding of [18F]SiTATE in Neuroendocrine Tumour Cells with Combined Inhibition of Class I HDACs and LSD1.
Journal: Neuroendocrinology
Published: May 22, 2024
Last Updated: 09/26/2026